Gene Query: BCL7B

Dataset Description Geneva Score
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 27.81
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 26.81
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 25.39
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 22.04
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 21.18
Nrf2 regulated genes in A549 cells 17.69
Identification of Nrf2 regulated genes by RNA sequencing 17.69
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 13.6
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 13.6
Conservative alteration of chromosomal expression pattern across human solid tumor types 13.49
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 13.47
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 13.03
Seletive inhibition of CDK9 in DLBCL cell lines 12.85
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 12.42
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.89
Genome wide expression change by RNF168 knocking down in MCF-7 cells 11.2
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 10.65
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 10.58
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 10.4
Transcriptome analysis of U87 cells upon LINC00152 knockdown 10.34
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 10.21
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 9.93
Rorc disruption in human FG pancreatic cancer cells 9.91
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 9.87
Active translatome profiling with RiboLace in MCF7 cells 9.79
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 9.74
An integrative analysis of non-coding regulatory DNA variations associated with autism 9.43
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.34
Effect of Hotair overexpression in human breast cancer cell lines 9.21
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 9.03
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 8.74
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 8.74
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.64
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.63
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.4
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 8.27
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 8.27
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 8.22
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 8.22
Impact of dieldrin on transcription in Jurkat T cells 8.21
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 8.21
Stem and effector CD8 T-cells from human cancers 8.17
CD73 knockdown effect in pancreatic cancer cell lines 8.17
Noncoding regions are the main source of targetable tumor-specific antigens 8.17
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.92
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.88
The evolution of N6-methyladenosine in primates 7.84
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.83
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 7.8
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.75
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 7.56
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 7.45
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.29
Identification of Sin3B regulated genes during quiescence 7.26
LNCaP treated with iBET 7.24
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 7.22
Neonatal and adult human testis defined at the single-cell level 7.16
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 7.15
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 7.09
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.02
SUV420H2 knockdown in PANC-1 6.98
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.95
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 6.93
Gene expression activation in CLL mediated by MSCs contact 6.87
Intrahepatic MAIT cell gene expression revealed by RNA-seq 6.84
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.83
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.8
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 6.7
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 6.65
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.61
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.59
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.59
ETV7 and interferon response 6.54
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.54
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 6.48
Altering cancer transcriptomes using epigenomic inhibitors 6.24
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.24
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.21
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.21
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.13
PTHrP overexpression in MCF7 cells 6.1
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.06
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 6.05
The comparison of high-throughput single-cell RNA-seq methods 6.01
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.96
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 5.95
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 5.95
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 5.93
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 5.9
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 5.9
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 5.9
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.86
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 5.86
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 5.81
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 5.81
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.76
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 5.74
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 5.73
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 5.72
Genome wide expression change by RNF168 knocking down in NEC cells 5.72
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.71
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.71
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 5.68
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 5.55
Fbxo32 mediated gene expression program underlies EMT and metastasis 5.52
METTL3 promotes translation in human cancer cells 5.51
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.49
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.48
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.47
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.47
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 5.42
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 5.39
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 5.39
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 5.36
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 5.36
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.36
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 5.33
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 5.28
AUF-1 affected genes in human skin cells 5.27
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.26
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.26
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 5.25
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.24
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 5.23
Differential gene expression of human melanoma cells [RNA-seq] 5.23
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 5.22
Dynamic 3D chromosomal landscapes in acute leukemia 5.22
Human Treg NaCl stimulation 5.22
TFAP2C signalling in human fibroblasts 5.21
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.21
MYCi975 regulates MYC target genes 5.21
CSL 5.17
CSL RNA-Seq on HKC and SCC cell lines 5.17
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.16
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.16
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.16
RNA sequencing of GlyH-101-treated MCF-7 cell line 5.12
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.09
Silencing SPIB in attached and floating state of H1703 lung cancer cells 5.09
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.07
Accurate annotation of human protein-coding small open reading frames 5.07
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 5.07
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 5.07
Paxillin regulates genomic networks in prostate cancer [PC3] 5.06
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 5.02
RIG-I and MDA5 fRIP during KSHV lytic reactivation 5.0
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 4.99
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 4.95
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.95
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 4.91
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 4.91
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 4.89
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.88
CROP-Seq in Primary Human T Cells 4.83
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.81
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 4.79
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.78
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.78
SNHG5 siRNA knock down in HCT116 cells 4.77
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 4.75
Human HAP1 cells before and after nutrient deprivation 4.75
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 4.75
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 4.75
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.74
hnRNP C is a key regulator of protein synthesis in mitosis 4.68
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 4.67
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 4.67
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 4.63
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 4.62
Expression and functions of long noncoding RNAs during human T helper cell differentiation 4.62
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 4.61
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 4.56
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 4.56
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.55
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.53
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 4.53
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 4.52
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.52
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.51
MAIT cell RNA sequencing 4.45
scRNASeq analysis of cycling cardiomyocytes 4.44
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.44
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.42
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.4
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 4.4
Zone dependent distinctive gene expression profile of the normal human liver tissue 4.38
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.37
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.37
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 4.32
The interplay between SOX4 and SMAD3 in the context of breast cancer 4.3
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 4.28
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 4.28
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.28
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.28
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 4.28
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 4.25
Expression data from miR340 overexpressing human A549 cells 4.24
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 4.23
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.22
Global analysis of enhancer targets: Mosaic-seq 4.21
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.2
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 4.19
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.19
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 4.19
Effect of drugs on transcriptomic profiles 4.19
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.16
Global epigenomic reconfiguration during mammalian brain development 4.16
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 4.15
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.14
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.12
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 4.08
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 4.04
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 4.04
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 4.04
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 4.01
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 4.01
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.01
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.96
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 3.95
Effect of PRDM11 depletion in U2932 cells 3.92
TGF-β regulation of miRNA expression in pancreatic cancer 3.91
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.91
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 3.9
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 3.9
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.88
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.87
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.85
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 3.84
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 3.83
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 3.82
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.8
FBXW7 modulates stress response by post-translational modification of HSF1 3.79
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.79
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 3.76
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 3.73
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.7
Nonpregnant and term pregnant human myometrial tissues 3.69
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 3.69
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 3.68
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.68
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.64
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 3.63
RNA editing in nascent RNA affects pre-mRNA splicing 3.62
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.62
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.62
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.62
Gene expression analysis of the impact of TDP-43 knockout in human cells. 3.62
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.57
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.56
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.54
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.54
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.53
KLF6-dependent transcription in renal cancer cells 3.52
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.51
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.51
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 3.51
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 3.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.47
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.47
Primary Human B-cell Temporal Response to CD40L Stimulation 3.46
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 3.46
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.46
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.45
RNA transcriptome analysis during HSV-1 infection 3.44
miRNAs affected by antagomiR-17 treatment 3.43
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 3.42
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.39
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 3.37
Co-regulation of splicing by Rbfox1 and hnRNP M 3.36
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 3.36
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.33
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 3.33
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.33
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.32
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.31
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.31
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.31
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 3.3
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.28
Illumina Total RNA-seq in HeLa 3.26
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 3.24
RNA-seq of YB5 cells treated with Proscillaridin A 3.23
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 3.23
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 3.22
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 3.21
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 3.18
TOP2B disturbed the quality of human oocytes with advanced maternal age 3.12
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.1
PRDM1 inhibits proliferation of human colon cancer organoids 3.06
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.06
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 3.0
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 3.0
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.99
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 2.93
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 2.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.91
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 2.9
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 2.9
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 2.9
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 2.86
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 2.86
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.86
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 2.82
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.8
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.8
The bromodomain protein BRD4 regulates splicing during heat shock 2.79
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.77
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.74
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.74
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 2.72
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 2.72
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 2.7
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 2.68
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.68
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.66
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 2.66
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 2.62
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 2.61
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 2.57
Regulation of protein translation during mitosis 2.57
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.55
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.52
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.51
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 2.5
Regulation of poly(A) tail and translation during the somatic cell cycle 2.49
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.49
Expression profiling of MCF-7 cells with treatment of TCDD 2.48
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.48
Single-cell analysis of adult human ovary using 10X genomics 2.45
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.45
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 2.43
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.42
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.42
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 2.38
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 2.36
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.33
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.33
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 2.32
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 2.32
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.3
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.27
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.26
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 2.23
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 2.22
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.21
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 2.18
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.16
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.11
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.1
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.05
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.05
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.05
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 2.05
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.03
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.03
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.03
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.0
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.99
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.99
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.98
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 1.98
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.96
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.96
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.9
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.88
Functional significance of the HIV-1 Tat signature amino acid residues 1.88
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 1.85
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.85
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 1.84
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 1.79
Identification of global XBP1s target gene expression in human prostate cancer cells 1.76
Functional Haploid Human Oocytes Generated from Polar Body Genomes 1.73
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 1.73
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.7
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 1.63
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.61
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.58
Analyses of T-ALL (COG study) 1.53
RNA sequencing of T-ALL (COG study) 1.53
Cellular response to hepatitis E virus (HEV) infection 1.53
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.52
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 1.51
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.5
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 1.49
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 1.49
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.45
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.45
RNA-Seq in neutrophils from Antiphospholipid Syndrome 1.39
NAPRT activation of macrophages 1.38
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 1.33
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.33
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.33
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.31
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.27
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.25
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.24
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.23
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.23
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 1.23
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.22
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.21
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.21
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.21
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.21
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.18
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.17
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.16
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.16
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.16
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.15
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.15
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.12
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.12
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.11
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.09
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.06
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.04
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.01
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.97
An optimization system for isolating and sequencing of single human colon cancer cells 0.96
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.93
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.93
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 0.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 0.89
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 0.89
SLAM-seq for K562 endogenous mRNA decay 0.88
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.87
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.87
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.87
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.87
RNA-seq differential expression studies: more sequence, or more replication? 0.85
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.85
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.84
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.83
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.82
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.8
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.79
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.78
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.78
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 0.78
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.78
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.77
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 0.75
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.75
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.75
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.73
mRNA differential expression analysis in a human ex vivo model of chronic wounds 0.73
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.7
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 0.68
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.68
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.68
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.66
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.64
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.63
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.6
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.59
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.57
Effects of transcription on genome - nuclear lamina interactions 0.57
Human Treg IFNg/IL-10 subpopulations 0.55
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.55
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.54
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.49
Metabolism as an early predictor of DPSCs aging 0.49
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.49
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.47
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.4
Human Treg IL-12 stimulation 0.31
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.3
Transcriptome sequencing of K-562 cells 0.29
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.28
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.26
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.24
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.21
Loss of CREBBP results in gene expression repression in lymphoma cells 0.21
MicroRNA-125a-5p overexpression in human macrophages 0.21
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.2
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.2
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.2
Oncogenic roles of ARID5B in T-ALL 0.2
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.19
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.19
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.16
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.14
Specific molecular signatures underlie response to decitabine in CMML 0.12
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.12
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.12
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.12
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 0.12
The role of the Calcium-Sensing receptor in colorectal cancer 0.1
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 0.09
MHC Transcriptomic landscape at haplotype-specific resolution 0.07
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.05
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.04
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.04
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.03
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 0.02
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.01
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.01
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation